Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina

Post navigation

← Pneumococcal carriage at age 2 months is associated with growth deficits at age 6 months among infants in South India

Human Papillomavirus vaccination in HIV-infected women: need for increased coverage →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

Translation Disclaimer